CHMP limits ipidacrine to specific neuropathies, Alzheimer’s, intestinal atony and certain stroke/TBI recovery uses; removes several neuritis and demyelinating indications; cautions >80 mg/day.
SAF reached 1.1 Mt (2.8% share), a near sixfold rise from 2024; supplied at 121 airports, 84% produced in the EU, and 18 Member States host production projects.
Regional platform mobilises 14 organisations to coordinate offshore wind, LNG/bioLNG, hydrogen, CCS, SMRs and infrastructure protection across the Baltic Sea region.
High natural gas and emission allowance costs could force cuts to ammonia output, pushing fertilizer prices beyond farmers’ budgets and threatening European harvests.
€2.5bn from the Modernisation Fund supports 51 projects across 11 lower-income EU states to modernise energy systems, expand renewables and cut greenhouse-gas emissions.
CRCF Days launched rollout: certification schemes may seek CRCF recognition; Buyers’ Club to aggregate demand; removals and carbon‑farming methodologies near adoption; financing and de‑risking needed
Distribution of Acticide and Microcare in Finland and the Baltics transfers May–June 2026, expanding supply for coatings, hygiene and cosmetics.
siRNA blocking APOC3 cut triglycerides 80% vs 17% in trial; lowered acute pancreatitis rates; given subcutaneously every 3 months; common AEs: hyperglycaemia, headache, nausea.
After the AGM, the Board elected: Personnel & Remuneration — Chair Pasi Laine; Nick Elmslie, Conrad Keijzer, Sari Mannonen. Audit — Chair Essimari Kairisto; John Abbott, Anna Hyvönen, Just Jansz.
Lithuania invests in renewable energy with a new biogas plant, aiming to reduce fossil fuel use and support decarbonization. Completion is set for April 2026.
